• Antisense therapy is a form of treatment that uses antisense oligonucleotides (ASOs) to target messenger RNA (mRNA). ASOs are capable of altering mRNA...
    23 KB (2,219 words) - 02:24, 20 August 2024
  • various cell types. Some alternative antisense structural types have been experimentally applied as antisense therapy. In the United States, the Food and...
    19 KB (2,444 words) - 17:30, 3 December 2023
  • properties to the oligonucleotides and make them a key element in antisense therapy. Oligonucleotides are chemically synthesized using building blocks...
    23 KB (2,581 words) - 08:14, 10 June 2024
  • Thumbnail for Cystic fibrosis
    function would provide an alternative to traditional antibiotic therapies. Antisense therapy is being researched to treat a subset of mutations which have...
    161 KB (18,151 words) - 09:04, 27 September 2024
  • Thumbnail for Antisense RNA
    Antisense RNA (asRNA), also referred to as antisense transcript, natural antisense transcript (NAT) or antisense oligonucleotide, is a single stranded...
    24 KB (2,997 words) - 00:53, 25 July 2024
  • Pelacarsen (category Antisense RNA)
    Pelacarsen is an antisense therapy that is designed to reduce Lipoprotein(a) concentrations in people with high levels of the lipoprotein and who are...
    2 KB (196 words) - 18:00, 11 August 2024
  • Thumbnail for Ionis Pharmaceuticals
    Ionis Pharmaceuticals (category Antisense RNA)
    of research of GlaxoSmithKline, with the goal of commercializing antisense therapy. In 1992, the company received its first approval by the Food and...
    16 KB (1,428 words) - 12:29, 20 September 2024
  • Thumbnail for RNA interference
    known as precise, efficient, stable and better than antisense therapy for gene suppression. Antisense RNA produced intracellularly by an expression vector...
    141 KB (15,474 words) - 08:09, 11 August 2024
  • Thumbnail for Gene therapy
    procedural practices. The modified gene therapy strategy of antisense IGF-I RNA (NIH n˚ 1602) using antisense / triple helix anti-IGF-I approach was registered...
    176 KB (18,162 words) - 23:14, 25 September 2024
  • Olpasiran (category Antisense RNA)
    Olpasiran (AMG890) is an experimental antisense therapy designed to lower the level of lipoprotein(a), which is believed to be a causal factor in the...
    2 KB (183 words) - 01:20, 17 January 2024